Literature DB >> 13489704

Effects of combinations of azaserine and of 6-diazo-5-oxo-L-norleucine with purine analogs and other antimetabolites on the growth of two mouse mammary carcinomas.

G S TARNOWSKI, C C STOCK.   

Abstract

Entities:  

Keywords:  BREAST NEOPLASMS/experimental; CYTOTOXIC DRUGS; LEUCINE/related compounds; SERINE/related compounds

Mesh：

Substances：

Year:  1957        PMID： 13489704

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  Experiments in immunity in cancer.

Authors:  G MURRAY
Journal:  Can Med Assoc J       Date:  1958-08-15       Impact factor: 8.262

2.  Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs.

Authors:  Lukáš Tenora; Jesse Alt; Ranjeet P Dash; Alexandra J Gadiano; Kateřina Novotná; Vijayabhaskar Veeravalli; Jenny Lam; Quinn R Kirkpatrick; Kathryn M Lemberg; Pavel Majer; Rana Rais; Barbara S Slusher
Journal:  J Med Chem       Date:  2019-03-29       Impact factor: 7.446

3.  The effect of 4-amino-5-imidazolecarboxamide on the synergistic antineoplastic activity of 6-chloropurine and azaserine.

Authors:  A C Sartorelli; B A Booth
Journal:  Experientia       Date:  1965-08-15

Review 4.  Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy.

Authors:  Diana Cervantes-Madrid; Yair Romero; Alfonso Dueñas-González
Journal:  Biomed Res Int       Date:  2015-09-06       Impact factor: 3.411

5.  High expression of GFAT1 predicts poor prognosis in patients with pancreatic cancer.

Authors:  Caiting Yang; Peike Peng; Lili Li; Miaomiao Shao; Junjie Zhao; Lan Wang; Fangfang Duan; Shushu Song; Hao Wu; Jie Zhang; Ran Zhao; Dongwei Jia; Mingming Zhang; Weicheng Wu; Can Li; Yefei Rong; Lei Zhang; Yuanyuan Ruan; Jianxin Gu
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

Review 6.  The Potential of Lonidamine in Combination with Chemotherapy and Physical Therapy in Cancer Treatment.

Authors:  Yaxin Huang; Guohui Sun; Xiaodong Sun; Feifan Li; Lijiao Zhao; Rugang Zhong; Yongzhen Peng
Journal:  Cancers (Basel)       Date:  2020-11-11       Impact factor: 6.639

7.  TOXICITY AND CLINICAL TRIAL OF AZASERINE AND 6-THIOGUANINE IN ADVANCED SOLID MALIGNANT NEOPLASMS.

Authors:  J M SCHROEDER; F J ANSFIELD; A R CURRERI; G A LEPAGE
Journal:  Br J Cancer       Date:  1964-09       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.